Alkermes plc Files Definitive Proxy Statement
Ticker: ALKS · Form: DEFA14A · Filed: 2025-05-12T00:00:00.000Z
Sentiment: neutral
Topics: proxy-statement, sec-filing, corporate-governance
Related Tickers: ALK
TL;DR
ALK proxy statement filed 5/12, shareholders get voting info.
AI Summary
Alkermes plc filed a Definitive Proxy Statement (DEFA14A) on May 12, 2025. This filing is related to the company's proxy materials, likely for an upcoming shareholder meeting. The document is a public filing and does not appear to be a preliminary or confidential statement.
Why It Matters
This filing provides shareholders with important information regarding company matters, including potential voting items and executive compensation, ahead of shareholder decisions.
Risk Assessment
Risk Level: low — This is a standard proxy filing, providing routine corporate information to shareholders.
Key Players & Entities
- Alkermes plc (company) — Registrant
- May 12, 2025 (date) — Filing Date
FAQ
What type of SEC filing is this?
This is a DEFA14A, a Definitive Proxy Statement filed with the SEC.
Who is the filing company?
The filing company is Alkermes plc.
On what date was this filing made?
The filing was made on May 12, 2025.
Is this a preliminary or definitive filing?
This is a Definitive Proxy Statement, indicated by the 'Definitive Proxy Statement' checkbox being selected.
What is the SIC code for Alkermes plc?
The Standard Industrial Classification (SIC) code for Alkermes plc is 2834, Pharmaceutical Preparations.
From the Filing
0000950170-25-069448.txt : 20250512 0000950170-25-069448.hdr.sgml : 20250512 20250512170355 ACCESSION NUMBER: 0000950170-25-069448 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250512 DATE AS OF CHANGE: 20250512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 981007018 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 25935879 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 DEFA14A 1 alks-20250512.htm DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )     Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material under §240.14a-12 ALKERMES PLC (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): x No fee required. o Fee paid previously with preliminary materials. o Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11       On May 12, 2025, Alkermes plc (the “Company”) sent an email to employees in connection with the Company’s 2025 annual general meeting of shareholders. A copy of the communication can be found below.       Dear Colleagues,   Each year around this time, Alkermes holds its annual general meeting of shareholders (the Annual Meeting). In connection with the 2025 Annual Meeting, we published our Proxy Statement, a copy of which may be found by clicking here . The Proxy Statement contains a series of proposals for our shareholders to consider and on which we ask that our shareholders vote. It also contains our Board’s recommendation as to how to vote on each proposal. I am writing to encourage you to exercise your rights as a shareholder of Alkermes and vote your Alkermes shares before our 2025 Annual Meeting, which is being held on May 21, 2025. All employees who owned shares of Alkermes on March 14, 2025 (known as the ‘Record Date’ for the Annual Meeting) are entitled to vote. Your vote is very important to Alkermes, and we encourage you to vote as soon as possible. To be counted, your vote must be received by May 20, 2025 at 11:59 p.m. ET (4:59 a.m. IST). If you have any questions about the proposals in the Proxy Statement or how to vote your shares, please feel free to reach out.   Thank you for your support.